Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Abbott Laboratories : NAMED INDUSTRY SUSTAINABILITY LEADER FOR THE EIGHTH YEAR IN A ROW ON THE DOW JONES SUSTAINABILITY INDEX

11/17/2020 | 08:54am EST

ABBOTT PARK - For the eighth consecutive year, Abbott (NYSE: ABT) has been named the industry leader in sustainability by the Dow Jones Sustainability Index (DJSI), one of the most prestigious global benchmarks for corporate sustainability.

As the Global Industry Leader in the Health Care Equipment & Supplies sector, the company earned top scores for governance/economic and social performance. This is the 16th consecutive year that Abbott has been recognized as a sustainability leader through its inclusion on the DJSI, including both the Dow Jones Sustainability World Index and North America Index.

'Sustainability in health care is about designing accessibility and affordability into the life-changing health technologies and products we create to help more people live healthier, fuller lives,' said Robert B. Ford, president and chief executive officer, Abbott. 'Abbott people have risen to that challenge this year, producing seven tests to help fight COVID-19 while continuing to advance new innovations in critical areas like diabetes, heart disease and nutrition, ultimately reaching nearly 2 billion people.'

Abbott's overall score of 86 was more than triple the average score of 28 for other companies in its industry sector. Abbott achieved the top industry score in 11 of DJSI's 25 specific governance/economic, social and environmental criteria, including strategy to improve access to drugs or products, health outcome contribution, social reporting, human capital development, risk & crisis management, information security/cybersecurity & systems availability, customer relationship management, marketing practices, environmental reporting, operational eco-efficiency and occupational health and safety.

In addition to being included on DJSI, Abbott was named the 2020 World-Changing Company of the Year by Fast Company and was highlighted on Fortune's Change the World list. Abbott was also ranked No. 1 for social responsibility in its industry sector on Fortune's Most Admired Companies list for seven consecutive years (2014-2020), and was named one of the 100 Best Corporate Citizens by 3BL Media for 12 consecutive years (2009-2020).

Abbott's continued recognition demonstrates our longstanding commitment to sustainable, responsible business. Looking ahead, Abbott will further extend this commitment with the launch of its 2030 sustainability plan later this year. With forward-looking targets closely aligned to Abbott's purpose of helping people live fuller lives through better health, our 2030 plan will build a stronger, more sustainable Abbott that better serves the many people who depend on us.

About Abbott

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 107,000 colleagues serve people in more than 160 countries.

Contact:

Angela Duff

Tel: +1-224-668-6894

(C) 2020 Electronic News Publishing, source ENP Newswire

All news about ABBOTT LABORATORIES
01/15ABBOTT LABORATORIES : To launch the neurosphere mypath digital health app design..
AQ
01/14ABBOTT : to Launch the NeuroSphere™ myPath™ Digital Health App Desig..
PR
01/14ABBOTT LABORATORIES : Ex-dividend day for
FA
01/13ABBOTT LABORATORIES : Announces fulfillment of federal government purchase of 15..
AQ
01/12ABBOTT LABORATORIES : Fulfills US Government's Order of 150 Million BinaxNOW COV..
MT
01/12ABBOTT : Announces Fulfillment of Federal Government Purchase of 150 Million Bin..
PR
01/11ABBOTT LABORATORIES : Receives FDA 510(k) Clearance for Rapid Handheld Blood Tes..
MT
01/11ABBOTT : Receives FDA 510(k) Clearance for the First Rapid Handheld Blood Test f..
PR
01/06ABBOTT : Hosts Conference Call for Fourth-Quarter Earnings
PR
2020ABBOTT LABORATORIES : - as vaccines roll out, americans see covid-19 testing as ..
AQ
More news
Financials (USD)
Sales 2020 33 854 M - -
Net income 2020 4 415 M - -
Net Debt 2020 11 794 M - -
P/E ratio 2020 45,4x
Yield 2020 1,29%
Capitalization 191 B 191 B -
EV / Sales 2020 5,98x
EV / Sales 2021 5,19x
Nbr of Employees 107 000
Free-Float 88,9%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | MarketScreener
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 120,22 $
Last Close Price 111,30 $
Spread / Highest target 21,3%
Spread / Average Target 8,02%
Spread / Lowest Target -26,3%
EPS Revisions
Managers and Directors
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Miles D. White Executive Chairman
Robert E. Funck Chief Financial Officer & Executive Vice President
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES1.65%190 701
MEDTRONIC PLC-0.28%157 229
BECTON, DICKINSON AND COMPANY4.60%76 127
HOYA CORPORATION-2.28%50 080
ALIGN TECHNOLOGY, INC.6.15%44 726
BAXTER INTERNATIONAL INC.-0.25%40 886